- Home
- EVLV vs AUTL Comparison
EVLV vs AUTL Comparison
Compare EVLV & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVLV
- AUTL
- Stock Information
- Founded
- EVLV 2013
- AUTL 2014
- Country
- EVLV United States
- AUTL United Kingdom
- Employees
- EVLV N/A
- AUTL N/A
- Industry
- EVLV Computer peripheral equipment
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EVLV Technology
- AUTL Health Care
- Exchange
- EVLV Nasdaq
- AUTL Nasdaq
- Market Cap
- EVLV 590.8M
- AUTL 590.8M
- IPO Year
- EVLV N/A
- AUTL 2018
- Fundamental
- Price
- EVLV $4.26
- AUTL $2.17
- Analyst Decision
- EVLV Strong Buy
- AUTL Strong Buy
- Analyst Count
- EVLV 5
- AUTL 3
- Target Price
- EVLV $5.60
- AUTL $10.20
- AVG Volume (30 Days)
- EVLV 1.8M
- AUTL 1.1M
- Earning Date
- EVLV 02-27-2025
- AUTL 03-13-2025
- Dividend Yield
- EVLV N/A
- AUTL N/A
- EPS Growth
- EVLV N/A
- AUTL N/A
- EPS
- EVLV N/A
- AUTL N/A
- Revenue
- EVLV $89,220,000.00
- AUTL $10,091,000.00
- Revenue This Year
- EVLV $28.84
- AUTL $851.83
- Revenue Next Year
- EVLV $30.41
- AUTL $224.65
- P/E Ratio
- EVLV N/A
- AUTL N/A
- Revenue Growth
- EVLV 17.67
- AUTL 82.71
- 52 Week Low
- EVLV $2.01
- AUTL $2.07
- 52 Week High
- EVLV $5.73
- AUTL $7.37
- Technical
- Relative Strength Index (RSI)
- EVLV 63.32
- AUTL 41.40
- Support Level
- EVLV $3.75
- AUTL $2.07
- Resistance Level
- EVLV $4.29
- AUTL $2.26
- Average True Range (ATR)
- EVLV 0.22
- AUTL 0.12
- MACD
- EVLV 0.07
- AUTL 0.01
- Stochastic Oscillator
- EVLV 92.17
- AUTL 25.00
About EVLV Evolv Technologies Holdings Inc.
Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and advanced sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase and primarily under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.